Low blood S-methyl-5-thioadenosine is associated with postoperative delayed neurocognitive recovery

Lei Zhang1,2, Haoli Mao3, Ren Zhou4

  • 1Department of Anesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. weiymzhl@126.com.

Communications Biology
|October 20, 2024
PubMed

Insights

Surgery and anesthesia can cause cognitive decline in elderly patients. Lower levels of S-methyl-5-thioadenosine (MTA) may predict this risk, offering a potential biomarker for delayed neurocognitive recovery (dNCR).

Area of Science:

  • Neuroscience
  • Metabolomics
  • Geriatrics

Background:

  • Elderly individuals experience metabolite alterations linked to postoperative cognitive impairment.
  • The relationship between specific metabolites and delayed neurocognitive recovery (dNCR) after surgery and anesthesia is not well understood.

Purpose of the Study:

  • To investigate the association between S-methyl-5-thioadenosine (MTA) and dNCR in elderly patients.
  • To identify blood metabolites as potential biomarkers for dNCR following anesthesia and surgery.

Main Methods:

  • Widely targeted metabolomics was used to analyze preoperative and postoperative plasma samples from mice and human patients.
  • MTA levels and MTA phosphorylase activity were assessed in mouse brains.
  • Cognitive function and inflammation were evaluated in mice following MTA administration.

Main Results:

  • Anesthesia/surgery decreased MTA levels and activated MTA phosphorylase in mouse brains.
  • Preoperative MTA administration in mice prevented inflammation and cognitive decline.
  • Patients who developed dNCR had lower preoperative serum MTA levels.
  • Both low preoperative and postoperative MTA levels correlated with an increased risk of dNCR.

Conclusions:

  • Anesthesia and surgery may induce cognitive decline via alterations in methionine synthesis pathways.
  • S-methyl-5-thioadenosine (MTA) shows potential as a perioperative biomarker for predicting dNCR.